Recent evidence suggests that ANG II and aldosterone may have significant metabolic effects and may contribute to the development and progression of insulin resistant conditions such as obesity, metabolic syndrome and cachexia [41,81,87-90]. The gene discussed is AGT; the disease is metabolic syndrome.